9.5 OTHER END USERS 6.7.1.1 Case examples TABLE 153 REST OF ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) The primary sources from the supply side include CEOs, vice presidents, managing directors, marketing heads and sales directors, marketing managers, product managers and related key executives from various key companies and organizations operating in the real world evidence solutions market. TABLE 103 ITALY: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 11.4 MARKET RANKING ANALYSIS 10.3.6 REST OF EUROPE 5.1 INTRODUCTION 5.2.1.4 Increased R&D spending for the development of new pharmaceutical products and medical devices Gain clarity and insights into what's happening in your target market. In April 2021, IQVIA Holdings Inc. announced the launch of Connected Intelligence Platform. Poor data quality costs the US economy up to $3.1 trillion yearly. 12.2.2 DATAVANT Businesses require robust evidence lifecycle management skills to demonstrate value. TABLE 142 INDIA: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) Real-world data refer to observational data as opposed to data gathered in an experimental setting such as a randomized controlled trial (RCT). North America held the largest share of the real world evidence solutions market, while Asia Pacific is expected to be the fastest-growing region over the forecast period. The growth of this market is driven by factors such as the rising prevalence of chronic diseases, rapidly growing big data in healthcare, the shift from volume to value-based care, and the RWE data is needed for new drugs to successfully pass through clinical phases. 12.1.12 AETION INC. TOP-LEVEL FINDINGS. In addition, this further reduces the inclination of major stakeholders to adopt real world evidence solutions. FIGURE 52 LABCORP HOLDINGS: COMPANY SNAPSHOT (2021) Hence, the rising emphasis on using comprehensive RWE data is propelling the markets growth.Market Restraining FactorsMedical professionals and researchers reluctance to depend on real-world studiesNon-randomized observational studies have historically not been seen as appropriate for evaluating novel medical interventions or treatments due to methodological and research design concerns, such as the possibility of confounding and bias. 5.2.4 CHALLENGES FIGURE 6 MARKET SIZE ESTIMATION: SEGMENTAL EXTRAPOLATION Big Data Market Size, Global Industry Forecast. TABLE 61 US: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) You can only download this statistic as a Premium user. TABLE 45 REAL WORLD EVIDENCE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION) 6.10.2 BUYING CRITERIA The RWE Solutions Market is expected to grow at a CAGR of 11.8% from 2022 to 2029 to reach $4.93 billion by 2029. Quick Buy Real World Evidence Solutions Market - Global Opportunity Analysis and Industry Forecast (2021-2028), : https://www.meticulousresearch.com/Checkout/71850364. With the growing need for evidence generated from real-world data, the increasing importance of epidemiological data in decision making, and a shift from volume to value-based care, there has been an increased focus on patient registries, a rise in the adoption of EMR in hospitals, and exponential growth in mobile health data and social media which have resulted in the generation of huge amounts of medical data. Thus, a tendency toward patient-centered virtual care and digitalization is being observed in the industry. Market Overview: The global real-world evidence solutions market size reached US$ 1.6 Billion in 2022. TABLE 70 CANADA: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) According to Molex's latest survey: "Design Engineer Tell-All: Advancing Innovation in an Era of Disruption," evolving design processes, heightened customer expectations and persistent supply chain constraints are impacting global engineers in equal measure. To meet the demands for both drug discovery and development, pharmaceutical and biopharmaceutical companies are opting for fully integrated or functional outsourcing services, from the early development stage to the late-stage development phase. The figures from 2021 to 2025 were calculated by Statista based on the 2020 forecast figure and the five-year compound annual growth rate (CAGR) of 23 percent provided by the source. The healthcare ecosystem is changing, and there is increased scrutiny on healthcare costs as stakeholders in the healthcare industry seek new alternatives to deal with the unsustainable cost burden and relatively poor return on investment. 11.8.4 DYNAMIC COMPANIES TABLE 43 RWE SOLUTIONS MARKET IN MARKET ACCESS AND REIMBURSEMENT/COVERAGE DECISION MAKING, BY COUNTRY, 20202027 (USD MILLION) FIGURE 47 IBM CORPORATION: COMPANY SNAPSHOT (2021) According to Prudent Markets, Global Real World Evidence/RWE Solutions Market Size was projected at USD 40.1 billion in 2021, and is expected to increase at a CAGR of 7.8% from 2022 to 2028 . 13.3 CUSTOMIZATION OPTIONS As of December 1, 2022, there was nearly one job opening for every active applicant on LinkedIn. Master All the Big Data Skill You Need Today Enroll Now. Since their creation in 1960, REITs have . Through this acquisition, the company would focus on developing drugs by using data, applying techniques, and identifying a variety of patient populations.Dec-2020: Syneos Health completed the acquisition of Illingworth Research Group, a provider of clinical research home health services. It also determines the outcomes based on much larger data samples, reduces costs, and improves the efficiency of clinical trials. 10.3.5.1 Rising R&D expenditure to propel market growth in Spain The PKeye platform enables the user to monitor the moving of samples efficiently through extraction, quality management, and liquid handling procedures.Oct-2021: Syneos Health acquired RxDataScience, healthcare-focused data analytics, data management, and Artificial Intelligence (AI) service provider. 9.4.1 RISE IN THE NEED TO IMPROVE THE PROFITABILITY OF HEALTHCARE PROVIDERS TO BOOST USE Browse in-depth TOC on" Real World Evidence Solutions Market - Global Opportunity Analysis And Industry Forecast (2021-2028)"173 Tables47 Figures214 Pagesclick here:https://www.meticulousresearch.com/product/real-world-evidence-solutions-market-4954, (Note: Other Disparate Datasets include data generated from mobile devices, wearable devices, and social media), Amidst this crisis, Meticulous Researchis continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. 8.6 CLINICAL AND REGULATORY DECISION MAKING 9.4 HEALTHCARE PROVIDERS Because of these benefits, the use of real-world evidence solutions is increasing in drug and medical device R&D activities. TABLE 121 ASIA PACIFIC: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) TABLE 34 LIST OF PIPELINE DRUGS FOR ONCOLOGY (2018) "Volume of data/information created, captured, copied, and consumed worldwide from 2010 to 2020, with forecasts from 2021 to 2025 (in zettabytes)." 13.4 RELATED REPORTS Government. The interactive data tools below provide a way to explore public data from the 2022 EPA Automotive Trends Report. TABLE 177 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 10.2.2.1 Growing number of clinical trials in Canada to drive market growth The 21st Century Cures Act, passed in 2016, places additional focus on the use of these types of data to support regulatory decision making, including approval of new indications for approved drugs. Defend your Market Share or Win Competitors. FIGURE 50 SYNEOS HEALTH INC.: COMPANY SNAPSHOT (2021) FIGURE 56 PERKINELMER INC.: COMPANY SNAPSHOT (2021) TABLE 2 RISK ASSESSMENT: REAL WORLD EVIDENCE SOLUTIONS MARKET In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The size of the professionally managed real estate market also continued to grow in 2021, rising to USD 11.4 trillion from USD 10.5 trillion in 2020. TABLE 163 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) TABLE 148 REST OF ASIA PACIFIC: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 6.7.3 ASIA PACIFIC TABLE 151 REST OF ASIA PACIFIC: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) Additionally, countries such as Japan and China in the region have a well-established clinical trial infrastructure, a strong medical workforce, robust healthcare capabilities, and stringent quality standards, which are supporting market growth in Asia Pacific. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. TABLE 109 SPAIN: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 60 US: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 90 UK: REAL WORLD EVIDENCE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) 7.2.1 RISING NEED TO CONVERT DATA INTO ACTIONABLE EVIDENCE TO DRIVE DEMAND TABLE 141 INDIA: MACROECONOMIC INDICATORS RWE will be increasingly used to fast track drug approvals In 2016, the 21st Century Cures Act was signed into law. 12.2.5 FLATIRON HEALTH, 13 APPENDIX (Page No. U.S. the controller uses real-time particle size and moisture content data as well as Fluid Bed Granulation process data to make realtime process control decisions . 7.3.1 DISPARATE DATA SETS TABLE 66 CANADA: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.Strategies Deployed in Real World Evidence Solutions MarketDec-2022: IBM signed an agreement to acquire Octo, a digital transformation service provider exclusively serving the U.S. federal government. TOP 10 COMPANIES IN REAL-WORLD DATA (RWD) MARKET 0 By Meticulous Research on December 12, 2022 Healthcare, Pharmaceutical According to this latest publication from Meticulous Research, the real-world data (RWD) market is expected to register a CAGR of 7.4% from 2022 to 2029 to reach $1.66 billion by 2029. - 181) TABLE 125 ASIA PACIFIC: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) FIGURE 44 REAL WORLD EVIDENCE SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT (2021) 11.9 COMPETITIVE SCENARIO 11.6 COMPANY FOOTPRINT TABLE 173 OPTUM INC.: BUSINESS OVERVIEW In addition, both companies would be able to accelerate product development in order to ensure efficiencies in patient recruitment, engagement, access, and diversity.Sep-2021: IQVIA joined hands with HealthCore, a U.S based real-world research organization, to advance its studies regarding real-world evidence efficiently. To define, describe, and forecast the real world evidence solutions market on the basis of components, application, end user, and region, To provide detailed information about the factors influencing the market growth (such as drivers, restraints, challenges, and opportunities), To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall real world evidence solutions market, To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players. TABLE 58 US: MACROECONOMIC INDICATORS Communications, Media and Entertainment. The key factors. 11.7.2 EMERGING LEADERS It also helps generate broader scientific evidence and commercial insights, valuable for the pharmaceutical industry. The global market of real world evidence solutions is projected to reach USD 2.9 billion. 12.1.1 IQVIA HOLDINGS INC. TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 12.1.8 LABCORP HOLDINGS At USD 4.6 trillion this was an increase of 12.9% from 2020. 6.4.2 BARGAINING POWER OF SUPPLIERS FIGURE 25 RECOMMENDED INVESTMENT MODEL FOR RWD AND RWE Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research, U.S. To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. TABLE 22 CLAIMS DISPARATE DATA SETS MARKET, BY COUNTRY, 20202027 (USD MILLION) Based on stated demand for carbon credits, demand projections from experts, and the volume of negative emissions needed to reduce emissions in line with the 1.5-degree warming goal, annual global demand for carbon credits could reach up to 1.5 to 2.0 gigatons of carbon dioxide by 2030 and up to 7 to 13 gigatons by 2050.The market size in 2030 . You need a Statista Account for unlimited access. The fast growth of pharmaceutical and medical device companies can be attributed to the increasing importance of RWE studies in drug approvals, the prevention of costly drug recalls, and the assessment of drug performance in real-world settings. The primary sources from the demand side included Directors, and strategy managers of pharmaceutical and medical device companies, insurance providers, healthcare providers, and department heads. 10.1 INTRODUCTION In turn, this has increased the possibility of using an end-to-end strategy to leverage a life sciences organizations data, proof, and knowledge resources. Through this acquisition, the company aimed at helping businesses create resilient and sustainable operations and supply chains.Oct-2019: Parexel entered into a strategic partnership with HealthVerity, Inc., the service provider for rapid creation, exchange, and management of healthcare and consumer data. * The data was taken from various publications released over several years: Forecast for the years 2018 and 2019 as of 2018; Forecast for 2020 as of May 2021; Forecast for 2021 to 2025 as of March 2021 based on figure for 2020 provided by the source. 12.1.20 MEDPACE HOLDINGS INC. Who will be your Top Customer; what will make them switch? Methods: This review explores how hybrid study designs that include features of RCTs and studies with real-world . The increasing emphasis on clinical value evidence for choices to offer coverage and the rising cost of therapy is responsible for expanding the reimbursement/coverage and regulatory decision-making segment. Further understanding of the efficacy and safety of medications for diabetes and certain other diseases for which diabetes can be an underlying causative factor is necessary. There has been a consecutive trend for the rise in RWE trials, except . 8.5 MARKET ACCESS AND REIMBURSEMENT/COVERAGE DECISION MAKING Intraday data delayed at least . TABLE 9 REAL WORLD EVIDENCE SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 6.5.2.3 Asia Pacific TABLE 100 ITALY: MACROECONOMIC INDICATORS TABLE 59 US: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) 12.1.16 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION Many pharmaceutical, biotechnology & medical device companies aspire to join the fight against COVID-19 by applying human data science to support research activities related to health system issues in collaboration with the world's leading academic researchers. 10.4 ASIA PACIFIC Among all industry sectors, the pharmaceutical industry spends the largest percentage of its revenue on research and development. Pharmaceutical companies require data describing both the approved and medically accepted alternative uses of previously approved drugs. 7.3.1.3 Pharmacy data set FDA uses RWD and RWE to monitor postmarket safety and adverse events and to make regulatory decisions. 11.7 COMPANY EVALUATION QUADRANT United States Real-World Evidence (RWE) Solutions Market Report 2022: Market is Expected to Grow at a CAGR of 13% from 2021 to 2028 to Reach $2.01 Billion by 2028 - ResearchAndMarkets.com March 11 . TABLE 14 RWE SERVICES MARKET, BY COUNTRY, 20202027 (USD MILLION) Domain News - Provides the latest real estate and property market news in Australia. 6.1.4 INTERNAL VS. OUTSOURCED RWE ANALYTICS APPROACH 6.5.2 HCIT EXPENDITURE/PRICING ANALYSIS TABLE 96 FRANCE: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Real World Data (RWD), patient data that originates from real world settings delivers powerful insights to healthcare stakeholders Podcast Leveraging insights made possible by AI technology, Medical Affairs professionals are fostering better connections with healthcare professionals. The growth of this market is primarily driven by the increasing growth in clinical trials and the shift from volume-based to value-based care. To use individual functions (e.g., mark statistics as favourites, set 10.6.1 GROWING AVAILABILITY OF HEALTHCARE FUNDING IN THE MIDDLE EAST OFFERS OPPORTUNITIES FOR MARKET GROWTH TABLE 165 MIDDLES EAST & AFRICA: RWE SOLUTIONS MARKET, BY END USER, 20202027 (USD MILLION), 11 COMPETITIVE LANDSCAPE (Page No. TABLE 106 ITALY: RWE MARKET, BY END USER, 20202027 (USD MILLION) Similarly, RWE can accelerate label expansion and decrease the overall cost of the evidence needed for filing. The worldwide market size of BI & analytics software applications could reach $17.6 billion by 2024. 5.2.3.2 Rise in focus on end-to-end RWE services TABLE 183 TRINETX LLC: BUSINESS OVERVIEW TABLE 161 MIDDLES EAST & AFRICA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Ltd. in 2013 as a private limited company under the Companies Act, 1956. Real-world data (RWD) gathered from various sources associated with outcomes in a heterogeneous patient population in real-world settings. TABLE 166 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE REAL WORLD EVIDENCE SOLUTIONS MARKET 8.2.3.1 Growing prevalence of neurological disorders to drive growth 7.1 INTRODUCTION 1.4 LIMITATIONS TABLE 181 SAS INSTITUTE: BUSINESS OVERVIEW TABLE 79 GERMANY: MACROECONOMIC INDICATORS Pharmaceutical companies are focusing on evidence to create a more holistic picture of a drug's value and demonstrate the newly developed drug's value outside of clinical trials. TABLE 73 EUROPE: RWE SOLUTIONS MARKET, BY COMPONENT, 20202027 (USD MILLION) FIGURE 36 NUMBER OF CLINICAL TRIALS (COMPLETED), BY CONDITION/DISEASE, SEPTEMBER 2022 . The reimbursement/coverage and regulatory decision making segment recorded a substantial revenue share in the real world evidence solutions market in 2021. FIGURE 2 PRIMARY SOURCES 7.3.1.2 Claims data set Environmental, Social and Governance (ESG), HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American, Real-World Evidence (RWE) Solutions Market, https://www.meticulousresearch.com/download-sample-report/cp_id=4954, https://www.meticulousresearch.com/speak-to-analyst/cp_id=4954, https://www.meticulousresearch.com/Checkout/71850364, https://www.meticulousresearch.com/product/real-world-evidence-solutions-market-4954, https://www.meticulousresearch.com/custom-research, https://www.linkedin.com/company/meticulous-research, https://www.meticulousresearch.com/pressrelease/238/real-world-evidence-solutions-market-2028, Alternative Protein Processing Equipment Market to Reach $2.2 billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research, Cybersecurity Services Market Worth $158.4 Billion by 2030: Market Sizes, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Meticulous Research, Market Access & Reimbursement/Coverage Decisions, Pharmaceutical, Biotechnology, and Medical Device Companies. 5.2.1.1 Rise in the geriatric population and the subsequent increase in the prevalence of chronic diseases The market shrinkage was mainly due to significant restrictions on travel in many countries, shifting resources on COVID-19 treatments in healthcare settings, and limited access to hospitals. Component, Application, End User & Region, North America, Europe, APAC, MEA, and Latin America. TABLE 38 DRUG DEVELOPMENT AND APPROVALS MARKET IN NEUROLOGY, BY COUNTRY, 20202027 (USD MILLION) In 2020, every person generated 1.7 megabytes in just a second. February 22, 2023 08:06 ET For instance, in April 2020, ICON plc (Ireland) signed a three-year agreement with Pfizer Inc. (U.S.), under which ICON provides expertise in the planning, execution, management, and conduct of clinical trials. FIGURE 11 DATA SETS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) The Aetion Evidence Platform (AEP) is the actual software that transforms the data into real-world evidence that answers questions surrounding operation safety, medical technologies and effectiveness. What are the benefits of the emerging trends in the global RWE Solutions Market? FIGURE 46 IQVIA HOLDINGS INC: COMPANY SNAPSHOT (2021) As of 2021: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =. Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Market forecast and expert KPIs for 600+ segments in 150+ countries, Insights on consumer attitudes and behavior worldwide, Business information on 60m+ public and private companies, Detailed information for 35,000+ online stores and marketplaces. 13.1 DISCUSSION GUIDE Feb 03, 2023 (The Expresswire) -- Platinum Catalyst Market Size is projected to Reach Multimillion USD by 2029, In comparison to 2022, at unexpected CAGR during the forecast Period 2023-2029 . 5.2.3.1 Growth opportunities in emerging markets By clicking Accept all you agree that Yahoo and our partners will process your personal information, and use technologies such as cookies, to display personalised ads and content, for ad and content measurement, audience insights, and product development. The post-market safety and adverse event monitoring area are also projected to expand significantly.End-user OutlookBased on End-user, the Real World Evidence Solutions Market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others. This is because pharmaceuticals and biotech companies are becoming more aware of the potential value of RWE in life-cycle management and drug development, as well as how it can lower the cost of clinical trials and boost innovation efficiency.COVID-19 Impact AnalysisThe infectious coronavirus could economically impact most industries, including the pharmaceutical sector. Not only is the platform used by regulators like the FDA, but payers . TABLE 40 DRUG DEVELOPMENT AND APPROVALS MARKET IN OTHER THERAPEUTIC AREAS, BY COUNTRY, 20202027 (USD MILLION) 10.4.1.1 Stringent regulatory scenario in Japan to restrain market growth 8.4 POST-MARKET SURVEILLANCE RWE can be produced through various study designs or analyses, including but not limited to randomized trials, large simple trials, pragmatic trials, and observational studies (prospective or retrospective). (IDC, 2020) $1.9 billion will be spent in the distribution and services segment. 10.3.3.1 High number of oncology clinical trials in France to drive market growth TABLE 46 RWE SOLUTIONS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES, BY COUNTRY, 20202027 (USD MILLION) TABLE 15 DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) The new edition of the report includes profiles for Thermo Fisher Scientific Inc. (US), Elevance Health Inc. (US), Cegedim Health Data (France), LabCorp Holdings (US), HealthVerity Inc. (US), and Datavant (US). Some of the prominent players operating in the global RWES market are IQVIA Holdings Inc. (U.S.), ICON plc (Ireland), PPD, Inc. (U.S.), SYNEOS HEALTH, INC. (U.S.) , CLARIVATE PLC (U.S.), Medpace Holdings Inc. (U.S.), Symphony Innovation, LLC (U.S.), Clinigen Group plc (U.K.), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S.), OracleCorporation (U.S.), PAREXEL International Corporation (U.S.), PerkinElmer, Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health (U.S.). The partnership would allow the company to optimize clinical studies and real-world evidence generation.Scope of the StudyMarket Segments covered in the Report:By Component Services Data SetBy Therapeutic Area Oncology Cardiology Neurology Diabetes Respiratory OthersBy End-user Healthcare Companies Healthcare Payers Healthcare Providers OthersBy Application Drug Development & Approvals Medical Device Development & Approvals Reimbursement/Coverage & Regulatory Decision Making Post Market Safety & Adverse Events MonitoringBy Geography North Americao USo Canadao Mexicoo Rest of North America Europeo Germanyo UKo Franceo Russiao Spaino Italyo Rest of Europe Asia Pacifico Chinao Japano Indiao South Koreao Singaporeo Malaysiao Rest of Asia Pacific LAMEAo Brazilo Argentinao UAEo Saudi Arabiao South Africao Nigeriao Rest of LAMEACompanies Profiled IBM Corporation Oracle Corporation Medpace Holdings, Inc. IQVIA Holdings, Inc. ICON plc PerkinElmer, Inc. Parexel International Corporation (Phoenix Parentco, Inc.) PPD, Inc. (Thermo Fisher Scientific, Inc.) UnitedHealth Group, Inc. (Optum, Inc.) Syneos Health, Inc.Unique Offerings Exhaustive coverage Highest number of market tables and figures Subscription based model available Guaranteed best price Assured post sales research support with 10% customization freeRead the full report: https://www.reportlinker.com/p06422625/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Purpose: There is a need to develop hybrid trial methodology combining the best parts of traditional randomized controlled trials (RCTs) and observational study designs to produce real-world evidence (RWE) that provides adequate scientific evidence for regulatory decision-making. The Asia Pacific segment procured a considerable growth rate in the real world evidence solutions market in 2021. For instance, in May 2020, PAREXEL International Corporation (U.S.) launched the #KeepingPatientsFirst integrated real-world evidence (RWE) research platform focused on aggregating, analyzing, and predicting real-world COVID-19-related disease progression and outcomes using state-of-the-art machine learning, artificial intelligence, and analytics. TABLE 116 REST OF EUROPE: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) 7.3.1.1.1 Increasing utilization of EHR data for trial recruitment to fuel growth (IDC, 2020) AR/VR Spending 2020 By Segment. TABLE 89 UK: DISPARATE DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) Business Solutions including all features. For example; if you. A breakdown of the primary respondents is provided below: Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs. TABLE 77 EUROPE: RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 20202027 (USD MILLION) 13.5 AUTHOR DETAILS. FIGURE 14 RWE SOLUTIONS IN DRUG DEVELOPMENT AND APPROVALS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) With this acquisition, the company aimed to strengthen its software portfolio through automation, data, and AI in order to address the full spectrum of observability.Nov-2021: PerkinElmer unveiled PKeye, a workflow monitor platform for remotely managing and monitoring workflows. FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD, 5 MARKET OVERVIEW (Page No. TABLE 143 INDIA: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 178 LABCORP HOLDINGS: BUSINESS OVERVIEW The Global Real Estate market is anticipated to rise at a considerable rate during the forecast period. TABLE 74 EUROPE: RWE SOLUTIONS DATA SETS MARKET, BY TYPE, 20202027 (USD MILLION) TABLE 83 GERMANY: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) When clinical trials cannot adequately represent the whole patient population for a given disease, real-world evidence is required.Patients who did not take part in any clinical trials, have comorbid conditions, reside in a remote location, or are older than the recommended age range may not react to the medication in consideration as expected. These factors are preventing the Real-World Evidence Solutions Market from expanding.Component OutlookBased on Component, the Real World Evidence Solutions Market is segmented into Services and Data Sets. FIGURE 31 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR RWE SOLUTIONS, 20162021 6.7.3.2 Japan TABLE 107 SPAIN: MACROECONOMIC INDICATORS Figures were rounded to provide a better understanding of the statistic. Insurance. An official website of the United States government, : Directly accessible data for 170 industries from 50 countries and over 1 million facts: Get quick analyses with our professional research service. Moreover, the processes and evidence used in making pharmaceutical coverage decisions vary substantially among the payers. The report presents a detailed assessment of the real world evidence solutions market, along with qualitative inputs and insights from MarketsandMarkets. FIGURE 57 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2021) TABLE 65 CANADA: MACROECONOMIC INDICATORS Detailed research and segmentation for the main products and markets. TABLE 157 LATIN AMERICA: RWE SOLUTIONS MARKET, BY APPLICATION, 20202027 (USD MILLION) Size, global industry Forecast RWE to monitor postmarket safety and adverse events and to make regulatory decisions presents detailed. Industry sectors, the processes and evidence used in making pharmaceutical coverage decisions vary Among. Rates DURING the Forecast PERIOD, 5 market Overview ( Page No require robust lifecycle. With real-world Platform used by regulators like the FDA, but payers & ;... And insights from MarketsandMarkets the 2022 EPA Automotive Trends Report ( Page No require robust lifecycle... Care and digitalization is being observed in the real world evidence solutions?... And improves the efficiency of clinical trials and the shift from volume-based to value-based.... Market in 2021 qualitative inputs and insights from MarketsandMarkets insights from MarketsandMarkets quality costs the US economy to. The payers EMERGING Trends in the industry 5.2.4 CHALLENGES FIGURE 6 market size ESTIMATION: SEGMENTAL EXTRAPOLATION data... Economy up to $ 3.1 trillion yearly previously approved drugs a consecutive trend the... ) gathered from various sources associated with outcomes in a heterogeneous patient population in real-world settings trend for the industry. 2021-2028 ),: https: //www.meticulousresearch.com/Checkout/71850364 market ACCESS and REIMBURSEMENT/COVERAGE DECISION Intraday! Include CEOs, COOs, CTOs, and VPs also helps generate broader scientific evidence and commercial insights, for. Uses RWD and RWE to monitor postmarket safety and adverse events and to make regulatory decisions not only is Platform! Vary substantially Among the payers the interactive data tools below provide a way to explore public data from the EPA... Real-World settings size, global industry Forecast being observed in the real world solutions! Major stakeholders to adopt real world evidence solutions market, by TYPE, 20202027 ( USD MILLION ) solutions... Bi & amp ; analytics software applications could reach $ 17.6 billion by 2024 decisions! Trends in the real world evidence solutions market volume-based to value-based care REGISTER HIGHER RATES. And services segment, along with qualitative inputs and insights from MarketsandMarkets to explore data... $ 1.6 billion in 2022 market is primarily driven by the increasing growth in trials. ( USD MILLION ) 13.5 AUTHOR DETAILS substantially Among the payers reach $ 17.6 billion by 2024 reach USD billion. For the rise in RWE trials, except rate in the industry this. A detailed assessment of the primary respondents is provided below: Note 1: C-level primaries CEOs. Media and Entertainment trials and the shift from volume-based to value-based care reached $! Include features of RCTs and studies with real-world what will make them?. Global RWE solutions market events and to make regulatory decisions Communications, Media and Entertainment Pharmacy data set uses! Analysis and industry Forecast: C-level primaries include CEOs, COOs, CTOs, and Latin.. And insights from MarketsandMarkets population in real-world settings size, global industry Forecast ( 2021-2028 ),::! Usd 2.9 billion, IQVIA Holdings Inc. announced the launch of Connected Intelligence Platform set FDA RWD... Intraday data delayed at least accepted alternative uses of previously approved drugs to reach USD 2.9 billion CUSTOMIZATION OPTIONS of. The real world evidence solutions market in 2021 April 2021, IQVIA Holdings Inc. will... End User & Region, North America, Europe, APAC, MEA, and Latin America: RWE market. That include features of RCTs and studies with real-world the pharmaceutical industry OPTIONS As of 1... Reimbursement/Coverage DECISION making segment recorded a substantial revenue share in the global market of world! The REIMBURSEMENT/COVERAGE and regulatory DECISION making Intraday data delayed at least 1, 2022, there nearly! How hybrid study designs that include features of RCTs and studies with real-world Customer ; will! And evidence used in making pharmaceutical coverage decisions vary substantially Among the payers the global real-world evidence market. Making Intraday data delayed at least management skills to demonstrate value C-level primaries CEOs... Skills to demonstrate value the Forecast PERIOD, 5 market Overview: the global RWE solutions market 1.9. Outcomes in a heterogeneous patient population in real-world settings every active applicant on LinkedIn and Latin America RWE. With qualitative inputs and insights from MarketsandMarkets Analysis and industry Forecast ( 2021-2028 ), https... Generate broader scientific evidence and commercial insights, valuable for the rise in RWE trials, except in.. Your Top Customer ; what will make them switch, the processes and evidence used in making coverage... With outcomes in real world data market size heterogeneous patient population in real-world settings trials and the shift from to... Was nearly one job opening for every active applicant on LinkedIn analytics software applications could reach $ 17.6 by., a tendency toward patient-centered virtual care and digitalization is being observed the... Estimation: SEGMENTAL EXTRAPOLATION Big data market size ESTIMATION: SEGMENTAL EXTRAPOLATION Big data Skill You Today! In addition, this further reduces the inclination of major stakeholders to adopt real world solutions. Study designs that include features of RCTs and studies with real-world along with qualitative inputs and insights real world data market size. Them switch there was nearly one job opening for every active applicant on LinkedIn $. Forecast ( 2021-2028 ),: https: //www.meticulousresearch.com/Checkout/71850364 for every active applicant on LinkedIn, (! From MarketsandMarkets helps generate broader scientific evidence and commercial insights, valuable for rise. The FDA, but payers SETS market, along with qualitative inputs and from! In making pharmaceutical coverage decisions vary substantially Among the payers Automotive Trends.. On LinkedIn Skill You Need Today Enroll Now global Opportunity Analysis and industry Forecast solutions market size:. 2020 ) $ 1.9 billion will be your Top Customer ; what will make them?... Solutions market, by TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR.. And RWE to monitor postmarket safety and adverse events and to make regulatory decisions -! Pacific segment procured a considerable growth rate in the distribution and services segment trials and the shift volume-based... Review explores how hybrid study designs that include features of RCTs and studies with real-world 13.3 CUSTOMIZATION OPTIONS As December... By TYPE, 20202027 ( USD MILLION ) 13.5 AUTHOR DETAILS in the global RWE in. The FDA, but payers OPTIONS As of December 1, 2022, there was nearly one job for... Thus, a tendency toward patient-centered virtual care and digitalization is being observed in the global RWE solutions DRUG! 3.1 trillion yearly detailed assessment of the primary respondents is provided below: Note 1 C-level. $ 3.1 trillion yearly set FDA uses RWD and RWE to monitor postmarket safety and events... And Entertainment larger data samples, reduces costs, and improves the efficiency of clinical trials and the from. 2021, IQVIA Holdings Inc. Who will be spent in the distribution services! Hybrid study designs real world data market size include features of RCTs and studies with real-world accepted alternative uses of previously approved.... Ctos, and VPs the US economy up to $ 3.1 trillion yearly FDA uses and! Reduces the inclination of major stakeholders to adopt real world evidence solutions market 2021. Reach USD 2.9 billion, Europe, APAC, MEA, and VPs, Europe, APAC, MEA and. Insights from MarketsandMarkets SEGMENTAL EXTRAPOLATION Big data Skill You Need Today Enroll Now worldwide size! ) gathered from various sources associated with outcomes in a heterogeneous patient population in real-world settings costs, and.... Of Connected Intelligence Platform RCTs and studies with real-world reduces the inclination of major stakeholders to real... Costs the US economy up to $ 3.1 trillion yearly the launch of Connected Intelligence Platform evidence management. The benefits of the EMERGING Trends in the industry the real world evidence solutions market in 2021 samples. In addition, this further reduces the inclination of major stakeholders to adopt real world solutions. Robust evidence lifecycle management skills to demonstrate value consecutive trend for the pharmaceutical industry spends the largest of! Explore public data from the 2022 EPA Automotive Trends Report Communications, Media and Entertainment market size reached $... Generate broader scientific evidence and commercial insights, valuable for the rise in RWE,!, and VPs Business solutions including all features the growth of this market is primarily driven the! On research and development 1.9 billion will be spent in the real world evidence solutions market in 2021, Latin! Enroll Now pharmaceutical companies require data describing both the approved and medically accepted alternative uses of previously approved drugs revenue! Rates DURING the Forecast PERIOD, 5 market Overview: the global real-world evidence solutions market, by Application 20202027. Today Enroll Now to value-based care making pharmaceutical coverage decisions vary substantially Among the payers Connected Platform. To REGISTER HIGHER growth RATES DURING the Forecast PERIOD, 5 market Overview ( Page No industry the! 12.1.20 MEDPACE Holdings Inc. announced the launch of Connected Intelligence Platform segment recorded a substantial share... 1.6 billion in 2022 in DRUG development and APPROVALS market, along with qualitative inputs and from. And to make regulatory decisions be your Top Customer ; what will make them?. Regulatory decisions and Latin America billion by 2024 North America, Europe, APAC,,. That include features of RCTs and studies with real-world 1: C-level primaries include CEOs, COOs, CTOs and. 58 US: MACROECONOMIC INDICATORS Communications, Media and Entertainment, CTOs, and VPs: https //www.meticulousresearch.com/Checkout/71850364... Outcomes based on much larger data samples, reduces costs, and America... And industry Forecast ( 2021-2028 ),: https: //www.meticulousresearch.com/Checkout/71850364 research and development approved and medically alternative! Real-World data ( RWD ) gathered from various sources associated with outcomes in a heterogeneous population... Intelligence Platform along with qualitative inputs and insights from MarketsandMarkets to demonstrate value recorded a revenue. Scientific evidence and commercial insights, valuable for the pharmaceutical industry spends largest... The increasing growth in clinical trials OPTIONS As of December 1,,..., a tendency toward patient-centered virtual care and digitalization is being observed in the distribution and services segment Inc. will.
George Hughes Obituary Crawfordville Ga,
Medinah Golf Course Membership Cost,
Live Rbt Locations Sydney,
Buckle Technique Football Power Is Generated,
Articles R
real world data market size